Medtronic Renews Commitment To Stent Market Via $3.7 Bil. AVE Purchase
This article was originally published in The Gray Sheet
Executive Summary
Developing the peripheral stent market will be a top priority for the combined Medtronic/Arterial Vascular Engineering vascular business upon completion of the two companies' $3.7 bil. merger agreement, Medtronic President and Chief Operating Officer Art Collins said during a Nov. 30 teleconference.